Resonance Health (RHT) Stock Price, News & Analysis

Company Overview

Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices in the Asia Pacific, North America, Europe, the Middle East, and Africa. The company offers FerriScan, a non-invasive MRI based system for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) assisted device for the automated real-time assessment of LIC; HepaFat-AI, an AI-trained device for the automated real-time multi-metric measurement of liver-fat; CardiacT2, a dual analysis service with FerriScan for assessing heart iron loading; HepaFat-Scan, a non-invasive MRI-based solution for the assessment of liver-fat in liver tissue; and LiverSmart, a non-invasive MRI-based multi-parametric device combining FerriSmart and HepaFat-AI into a consolidated report. It also provides quantitative imaging measurements and CRO services, such as quality-assured image analysis, project and data management, and issue resolution services; biomarkers, genomics, and laboratory analysis services, as well as works with third party pathology laboratories for blood/sample collection and for standard biochemical/lab safety assessments; design and protocol development, and project management and monitoring services; assessment of subject inclusion or exclusion, evaluating the safety profile of a new therapy, and supporting primary and secondary end-points demonstrating drug efficacy services; and phantoms for the MRI machines. The company serves clinicians for the management of human diseases; and pharmaceutical and therapeutic companies for their clinical trials. Resonance Health Limited was incorporated in 1987 and is headquartered in Burswood, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 2.57 million shs
• Average Volume: N/A
• Market Capitalization: $28.50 million
• P/E Ratio: 168.79
• Dividend Yield: 5.77%
• Price Target: N/A
• Consensus Rating: N/A

RHT Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Resonance Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Resonance Health investors own include ZIP (Z1P), Vital Metals (VML), QX Resources (QXR) and DXN (DXN).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: ASX:RHT
• CUSIP: N/A
• CIK: N/A
• Web: www.resonancehealth.com
• Phone: 61 8 9286 5300
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 168.79
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-1,090,000.00
• Net Margins: 1.97%
• Pretax Margin: N/A
• Return on Equity: 1.63%
• Return on Assets: -2.30%

Debt

• Debt-to-Equity Ratio: 33.81
• Current Ratio: 1.51
• Quick Ratio: 9.76

Sales & Book Value

• Annual Sales: $8.59 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 22.50
• Book Value: A$0.02 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 446,890,000
• Free Float: N/A
• Market Cap: $28.50 million
• Optionable: Not Optionable
• Beta: 1.32